F

Frenova Renal Research | Renal Associates of Baton Rouge, LLC

Research site

(Unclaimed)

Location

5131 O’Donovan Drive, First Floor, Baton Rouge, Louisiana, United States of America

Site insights

Top conditions

Top treatments

Bardoxolone Methyl

VX-147

Sevelamer Hydrochloride

Tenapanor

Bosutinib

KRX-0502

Ferric Citrate

BI 685509

Inaxaplin

Iron

Parent organization

This site is a part of Frenova Renal Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 17 total trials

Locations recently updated

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China (RESPOND-2)

The goal of this clinical trial is to learn if AP301 could work in the patients receiving maintenance dialysis with elevated blood phosphate. The mai...

Enrolling

ESRD (End-Stage Renal Disease)

Dialysis

Drug: AP301 Low Dose

Drug: AP301

Locations recently updated

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserv...

Enrolling

Immunoglobulin A Nephropathy

Drug: Placebo (matched to Povetacicept)

Drug: Povetacicept

Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities (AMPLIFIED)

The purpose of the study is to evaluate the efficacy, safety, and tolerability of Inaxaplin (IXP) in participants with proteinuric APOL1- mediated ki...

Enrolling

Proteinuric Kidney Disease

Drug: Inaxaplin

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease (AMPLITUDE)

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...

Enrolling

Proteinuric Kidney Disease

Drug: Placebo

Drug: VX-147